Nine online talking-therapy treatments for anxiety or depression have been given the green light to be used by the NHS in England. [Read more…] about The National Health Service (NHS) in England to roll-out nine online cognitive-behavioural therapies (CBT) for adults with anxiety or depression
A fascinating study just published in Nature Mental Health aimed at helping predict the outcomes of psychotherapy for patients with Post-Traumatic Stress Disorder (PTSD) using Machine Learning (ML) and electroencephalography (EEG) data.
PTSD is a mental health condition triggered by experiencing or witnessing a traumatic event; two evidence-based treatments–Prolonged Exposure (PE) and Cognitive Processing Therapy (CPT)–are commonly used to help patients, with varied results.
In this study, the researchers used a supervised machine learning approach and high-density resting-state EEG (rsEEG) recordings to predict individual psychotherapy outcomes. They identified a pretreatment EEG connectivity signature in the eyes-open theta frequency range that was predictive of patients’ responses to both PE and CPT. [Read more…] about Study shows the power of electroencephalography and machine learning to help predict response to psychotherapy (or lack thereof) in patients with PTSD
For people with post-traumatic stress disorder, recalling memories of physical or sexual assault, combat or disaster-related events can induce intense anxiety or panic attacks as well as debilitating flashbacks.
In the U.S., about 7% of people suffer from PTSD and lose an average of about four working days each month as a result. Trauma-specific psychotherapy, like cognitive processing or “talk” therapy, is the cornerstone of treatment for PTSD. But for approximately half of people, these traditional approaches are ineffective at fully addressing PTSD symptoms over the long term. Antidepressant drugs are frequently used if psychotherapy fails, or in combination with it, but the effects are usually modest. [Read more…] about Why MDMA-assisted psychotherapy may become an FDA-approved treatment for PTSD within 2 years
Post-traumatic stress disorder is a crippling, hard-to-treat psychiatric affliction. America spends billions of dollars yearly just on the veterans who suffer from PTSD. So it’s heartening to see the report of a promising new treatment, published Monday in Nature Medicine. [Read more…] about Study finds MDMA-assisted therapy to be safe and highly effective to treat severe PTSD
The FDA granted Minneapolis-based NightWare a De Novo clearance on Friday for its Apple Watch and iPhone app designed to improve the sleep quality of those experiencing nightmare disorder and nightmares related to PTSD. [Read more…] about FDA grants clearance for NightWare app designed to reduce PTSD-related nightmares
Hoping you enjoy this slidedeck supporting a great discussion held during the 2019 SharpBrains Virtual Summit: The Future of Brain Health (March 7–9th). Full recordings are available for purchase here.
9–10.30am. How to detect problems early: Examples in Alzheimer’s Disease, Parkinson’s, anxiety and PTSD
- Dr. Srijan Sen, Professor of Depression and Neurosciences at University of Michigan
- Jan Samzelius, Co-Founder and Chief Scientist of NeuraMetrix
- Dr. Tony Chang, Associate at Merck Ventures
- Chaired by: Dr. Deanna Belsky, Associate at Dolby Family Ventures